QQQ   383.49 (+0.92%)
AAPL   152.76 (+2.63%)
MSFT   323.06 (-0.03%)
FB   313.59 (+0.44%)
GOOGL   2,908.76 (-0.53%)
TSLA   1,071.37 (+3.23%)
AMZN   3,444.39 (+1.53%)
NVDA   248.18 (+1.50%)
BABA   169.65 (+0.25%)
NIO   39.91 (+1.53%)
CGC   13.07 (+2.27%)
GE   104.22 (+0.36%)
AMD   122.37 (+0.07%)
MU   69.65 (+2.07%)
T   25.52 (+1.84%)
F   16.88 (+8.83%)
ACB   6.95 (+1.61%)
DIS   169.96 (+0.24%)
PFE   43.28 (+0.72%)
BA   206.19 (-0.20%)
AMC   35.49 (+2.10%)
QQQ   383.49 (+0.92%)
AAPL   152.76 (+2.63%)
MSFT   323.06 (-0.03%)
FB   313.59 (+0.44%)
GOOGL   2,908.76 (-0.53%)
TSLA   1,071.37 (+3.23%)
AMZN   3,444.39 (+1.53%)
NVDA   248.18 (+1.50%)
BABA   169.65 (+0.25%)
NIO   39.91 (+1.53%)
CGC   13.07 (+2.27%)
GE   104.22 (+0.36%)
AMD   122.37 (+0.07%)
MU   69.65 (+2.07%)
T   25.52 (+1.84%)
F   16.88 (+8.83%)
ACB   6.95 (+1.61%)
DIS   169.96 (+0.24%)
PFE   43.28 (+0.72%)
BA   206.19 (-0.20%)
AMC   35.49 (+2.10%)
QQQ   383.49 (+0.92%)
AAPL   152.76 (+2.63%)
MSFT   323.06 (-0.03%)
FB   313.59 (+0.44%)
GOOGL   2,908.76 (-0.53%)
TSLA   1,071.37 (+3.23%)
AMZN   3,444.39 (+1.53%)
NVDA   248.18 (+1.50%)
BABA   169.65 (+0.25%)
NIO   39.91 (+1.53%)
CGC   13.07 (+2.27%)
GE   104.22 (+0.36%)
AMD   122.37 (+0.07%)
MU   69.65 (+2.07%)
T   25.52 (+1.84%)
F   16.88 (+8.83%)
ACB   6.95 (+1.61%)
DIS   169.96 (+0.24%)
PFE   43.28 (+0.72%)
BA   206.19 (-0.20%)
AMC   35.49 (+2.10%)
QQQ   383.49 (+0.92%)
AAPL   152.76 (+2.63%)
MSFT   323.06 (-0.03%)
FB   313.59 (+0.44%)
GOOGL   2,908.76 (-0.53%)
TSLA   1,071.37 (+3.23%)
AMZN   3,444.39 (+1.53%)
NVDA   248.18 (+1.50%)
BABA   169.65 (+0.25%)
NIO   39.91 (+1.53%)
CGC   13.07 (+2.27%)
GE   104.22 (+0.36%)
AMD   122.37 (+0.07%)
MU   69.65 (+2.07%)
T   25.52 (+1.84%)
F   16.88 (+8.83%)
ACB   6.95 (+1.61%)
DIS   169.96 (+0.24%)
PFE   43.28 (+0.72%)
BA   206.19 (-0.20%)
AMC   35.49 (+2.10%)
NASDAQ:NYXH

Nyxoah Stock Forecast, Price & News

$24.00
0.00 (0.00 %)
(As of 10/27/2021 12:00 AM ET)
Add
Compare
Today's Range
$22.76
$24.00
50-Day Range
$24.65
$33.00
52-Week Range
$20.00
$37.00
Volume
914 shs
Average Volume
17,093 shs
Market Capitalization
$598.63 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive NYXH News and Ratings via Email

Sign-up to receive the latest news and ratings for Nyxoah and its competitors with MarketBeat's FREE daily newsletter.


About Nyxoah

Nyxoah S.A., a health-technology company, focuses on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. It offers Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treast moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is based in Mont-Saint-Guibert, Belgium.

Headlines

Nyxoah (NASDAQ:NYXH) Sees Strong Trading Volume
October 27, 2021 |  americanbankingnews.com
Nyxoah (NASDAQ:NYXH) Shares Gap Up to $22.00
October 25, 2021 |  americanbankingnews.com
Nyxoah (NASDAQ:NYXH) Reaches New 12-Month Low at $20.00
October 22, 2021 |  americanbankingnews.com
Nyxoah (NASDAQ:NYXH) Shares Down 8.6%
October 21, 2021 |  americanbankingnews.com
Nyxoah (NASDAQ:NYXH) Shares Gap Down to $26.89
October 18, 2021 |  americanbankingnews.com
Nyxoah S.A. (NASDAQ:NYXH) Short Interest Update
October 15, 2021 |  americanbankingnews.com
Nyxoah (NASDAQ:NYXH) Shares Gap Down to $28.00
October 11, 2021 |  americanbankingnews.com
See More Headlines

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:NYXH
Phone
N/A
Employees
78
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
$598.63 million
Next Earnings Date
11/30/2021 (Estimated)
Fiscal Year End
N/A
Optionable
Not Optionable

MarketRank

Overall MarketRank

1.70 out of 5 stars

Medical Sector

883rd out of 1,372 stocks

Surgical & Medical Instruments Industry

91st out of 125 stocks

Analyst Opinion: 3.5Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












Nyxoah (NASDAQ:NYXH) Frequently Asked Questions

Is Nyxoah a buy right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Nyxoah in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Nyxoah stock.
View analyst ratings for Nyxoah
or view top-rated stocks.

What stocks does MarketBeat like better than Nyxoah?

Wall Street analysts have given Nyxoah a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Nyxoah wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Nyxoah?

Nyxoah saw a drop in short interest in the month of October. As of October 15th, there was short interest totaling 13,600 shares, a drop of 44.0% from the September 30th total of 24,300 shares. Based on an average daily trading volume, of 9,500 shares, the short-interest ratio is presently 1.4 days. Currently, 0.2% of the shares of the stock are sold short.
View Nyxoah's Short Interest
.

When is Nyxoah's next earnings date?

Nyxoah is scheduled to release its next quarterly earnings announcement on Tuesday, November 30th 2021.
View our earnings forecast for Nyxoah
.

What price target have analysts set for NYXH?

4 analysts have issued 1 year price targets for Nyxoah's shares. Their forecasts range from $40.00 to $43.00. On average, they anticipate Nyxoah's stock price to reach $42.00 in the next twelve months. This suggests a possible upside of 75.0% from the stock's current price.
View analysts' price targets for Nyxoah
or view top-rated stocks among Wall Street analysts.

Who are Nyxoah's key executives?

Nyxoah's management team includes the following people:
  • Mr. Robert Taub MBA, Co-Founder & Chairman (Age 74, Pay $91.11k)
  • Mr. Olivier Taelman, Exec. Director & CEO (Age 50, Pay $396.15k)
  • Mr. Fabian Suarez Gonzalez, Chief Financial Officer (Age 47)
  • Ms. Dorit Nahari, VP of Operations
  • Mr. Bruno Onkelinx, Chief Technology Officer
  • Ms. An Moonen, Gen. Counsel

When did Nyxoah IPO?

(NYXH) raised $83 million in an IPO on Friday, July 2nd 2021. The company issued 2,760,000 shares at $30.00 per share.

What is Nyxoah's stock symbol?

Nyxoah trades on the NASDAQ under the ticker symbol "NYXH."

When does Nyxoah's lock-up period expire?

Nyxoah's lock-up period expires on Wednesday, December 29th. Nyxoah had issued 2,835,000 shares in its IPO on July 2nd. The total size of the offering was $85,050,000 based on an initial share price of $30.00. Shares of the company owned by company insiders and major shareholders will be eligible for trade following the end of the lock-up period.

How do I buy shares of Nyxoah?

Shares of NYXH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Nyxoah's stock price today?

One share of NYXH stock can currently be purchased for approximately $24.00.

How much money does Nyxoah make?

Nyxoah has a market capitalization of $598.63 million.

How many employees does Nyxoah have?

Nyxoah employs 78 workers across the globe.

What is Nyxoah's official website?

The official website for Nyxoah is www.nyxoah.com.

How can I contact Nyxoah?

The company can be reached via email at [email protected].


This page was last updated on 10/28/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.